Multicenter clinical trials phase ii as topic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Organisms2

Polygonum Coxiella

Diseases42

Wrist Injuries Neoplasms Disease Progression Lung Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis Breast Neoplasms Neutropenia Recurrence Nausea Carcinoma, Non-Small-Cell Lung Leukopenia Colorectal Neoplasms Thrombocytopenia Brain Neoplasms Drug-Related Side Effects and Adverse Reactions Vomiting Melanoma Stroke Acute Disease Ovarian Neoplasms Hematologic Diseases HIV Infections Prostatic Neoplasms Fatigue Kidney Neoplasms Pain Postoperative Complications Chronic Disease Stomach Neoplasms Diarrhea Carcinoma, Renal Cell Carcinoma, Squamous Cell Head and Neck Neoplasms Peritoneal Neoplasms Pancreatic Neoplasms Lymphoma, Non-Hodgkin Liver Neoplasms Myocardial Infarction Carcinoma, Small Cell Asthenia Sarcoma

Chemicals and Drugs62

Antineoplastic Agents Deoxycytidine Placebos Paclitaxel Cisplatin Fluorouracil Taxoids Antibodies, Monoclonal, Humanized Organoplatinum Compounds Antineoplastic Agents, Phytogenic Camptothecin Antibodies, Monoclonal Carboplatin Antimetabolites, Antineoplastic Vinblastine Doxorubicin Dacarbazine Leucovorin Quinazolines Cyclophosphamide Antineoplastic Agents, Alkylating Drug Combinations Benzenesulfonates Etoposide Phenylurea Compounds Drugs, Investigational Niacinamide Angiogenesis Inhibitors Vincristine Epothilones Tegafur Thalidomide Biological Markers Epirubicin Pyrroles Oxonic Acid Prednisone Recombinant Proteins Pyridines Pyrazines Methotrexate Ifosfamide Antibodies, Monoclonal, Murine-Derived Pyrimidines Protein Kinase Inhibitors Tumor Markers, Biological Anti-Bacterial Agents Immunosuppressive Agents Bridged Compounds Anthracyclines Sirolimus Cancer Vaccines Boronic Acids Interferon-alpha Granulocyte Colony-Stimulating Factor NAD(P)H Dehydrogenase (Quinone)Piperazines Indoles Antibiotics, Antineoplastic Anticoagulants Triazoles Sulfonamides

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Multicenter Studies as Topic Clinical Trials as Topic Treatment Outcome Double-Blind Method Prospective Studies Research Design Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Reproducibility of Results Follow-Up Studies Sensitivity and Specificity Predictive Value of Tests Clinical Trials, Phase III as Topic Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase I as Topic Infusions, Intravenous Survival Analysis Disease-Free Survival Controlled Clinical Trials as Topic Patient Selection Survival Rate Placebos Drug Evaluation Administration, Oral Combined Modality Therapy Clinical Protocols Single-Blind Method Drug Therapy, Combination Endpoint Determination Neoplasm Staging Kaplan-Meier Estimate Maximum Tolerated Dose Prognosis Pilot Projects Severity of Illness Index Sample Size Risk Factors Feasibility Studies Clinical Trials, Phase IV as Topic Risk Assessment Remission Induction Early Termination of Clinical Trials Salvage Therapy Questionnaires Treatment Failure Retrospective Studies Chemotherapy, Adjuvant Cohort Studies Meta-Analysis as Topic Neoadjuvant Therapy Pain Measurement Multivariate Analysis Data Interpretation, Statistical Cross-Over Studies Proportional Hazards Models Injections, Intravenous Area Under Curve Drug Approval Incidence Injections, Subcutaneous Analysis of Variance Random Allocation Probability Statistics, Nonparametric Immunotherapy Chi-Square Distribution Logistic Models Phytotherapy Exercise Therapy Radiotherapy, Adjuvant Evaluation Studies as Topic Registries Interviews as Topic Magnetic Resonance Imaging Confidence Intervals Statistics as Topic

Psychiatry and Psychology2

Patient Compliance Pain

Phenomena and Processes12

Time Factors Sensitivity and Specificity Metabolic Detoxication, Phase II Dose-Response Relationship, Drug Maximum Tolerated Dose Drug Resistance, Neoplasm Area Under Curve Pain Probability Chi-Square Distribution Pregnancy Recovery of Function

Disciplines and Occupations7

Surgery, Plastic Research Design Evidence-Based Medicine Outcome Assessment (Health Care)Biomedical Research Medical Oncology Statistics as Topic

Anthropology, Education, Sociology and Social Phenomena7

Quality of Life Patient Education as Topic Drug Approval Informed Consent United States Food and Drug Administration National Institutes of Health (U.S.)National Cancer Institute (U.S.)

Technology, Industry, Agriculture3

Dietary Supplements Quality Control Drug Industry

Humanities1

Quality of Life

Information Science12

Survival Rate Questionnaires Periodicals as Topic Review Literature as Topic Data Interpretation, Statistical Abstracting and Indexing as Topic Incidence Textbooks as Topic Terminology as Topic Registries Interviews as Topic Publishing

Named Groups2

Research Subjects Infant, Newborn

Health Care71

Multicenter Studies as Topic Clinical Trials as Topic Treatment Outcome Double-Blind Method Prospective Studies Randomized Controlled Trials as Topic Clinical Trials, Phase II as Topic Reproducibility of Results Follow-Up Studies Sensitivity and Specificity Predictive Value of Tests Clinical Trials, Phase III as Topic Clinical Trials, Phase I as Topic Survival Analysis Disease-Free Survival Controlled Clinical Trials as Topic Patient Selection Survival Rate Clinical Protocols Single-Blind Method Kaplan-Meier Estimate Clinical Trials Data Monitoring Committees Pilot Projects Severity of Illness Index Sample Size Risk Factors Feasibility Studies Clinical Trials, Phase IV as Topic Risk Assessment Early Termination of Clinical Trials Questionnaires Treatment Failure Retrospective Studies Outcome Assessment (Health Care)Congresses as Topic Guidelines as Topic Safety Cohort Studies Cost-Benefit Analysis Practice Guidelines as Topic Intention to Treat Analysis Patient Education as Topic Patient Compliance Meta-Analysis as Topic Multivariate Analysis Data Interpretation, Statistical Cross-Over Studies Proportional Hazards Models Area Under Curve Informed Consent Incidence Placebo Effect Research Support as Topic Age Factors Analysis of Variance United States Food and Drug Administration Random Allocation Probability Statistics, Nonparametric Patient Satisfaction Chi-Square Distribution Logistic Models Patient Participation Benchmarking Evaluation Studies as Topic National Institutes of Health (U.S.)Registries Interviews as Topic Confidence Intervals National Cancer Institute (U.S.)Statistics as Topic

Geographicals6

United States Europe Germany Italy Japan Canada

Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Multicenter Studies as Topic Clinical Trials as Topic Polygonum Treatment Outcome Surgery, Plastic Wrist Injuries Double-Blind Method Prospective Studies Research Design Randomized Controlled Trials as Topic Time Factors Clinical Trials, Phase II as Topic Reproducibility of Results Follow-Up Studies United States Sensitivity and Specificity Predictive Value of Tests Clinical Trials, Phase III as Topic Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase I as Topic Metabolic Detoxication, Phase II Antineoplastic Agents Infusions, Intravenous Survival Analysis Disease-Free Survival Controlled Clinical Trials as Topic Patient Selection Deoxycytidine Neoplasms Survival Rate Placebos Drug Evaluation Paclitaxel Dose-Response Relationship, Drug Administration, Oral Combined Modality Therapy Cisplatin Fluorouracil Taxoids Clinical Protocols Disease Progression Lung Neoplasms Single-Blind Method Drug Therapy, Combination Antibodies, Monoclonal, Humanized Endpoint Determination Neoplasm Staging Quality of Life Kaplan-Meier Estimate Neoplasm Recurrence, Local Organoplatinum Compounds Neoplasm Metastasis Maximum Tolerated Dose Breast Neoplasms Neutropenia Clinical Trials Data Monitoring Committees Antineoplastic Agents, Phytogenic Camptothecin Prognosis Recurrence Pilot Projects Severity of Illness Index Sample Size Risk Factors Feasibility Studies Antibodies, Monoclonal Clinical Trials, Phase IV as Topic Carboplatin Evidence-Based Medicine Risk Assessment Nausea Antimetabolites, Antineoplastic Carcinoma, Non-Small-Cell Lung Remission Induction Early Termination of Clinical Trials Salvage Therapy Leukopenia Vinblastine Doxorubicin Dacarbazine Questionnaires Treatment Failure Retrospective Studies Periodicals as Topic Leucovorin Chemotherapy, Adjuvant Quinazolines Outcome Assessment (Health Care)Congresses as Topic Cyclophosphamide Antineoplastic Agents, Alkylating Guidelines as Topic Safety Cohort Studies Europe Drug Combinations Colorectal Neoplasms Thrombocytopenia Cost-Benefit Analysis

No FAQ available that match "multicenter clinical trials phase ii as topic"